Imatron has concluded an agreement with a German foundation to support a $5 million study of coronary atherosclerosis, using the company’s patented electron beam tomography technology.Researchers plan to recruit 4500 men and women from a random
Imatron has concluded an agreement with a German foundation to support a $5 million study of coronary atherosclerosis, using the companys patented electron beam tomography technology.
Researchers plan to recruit 4500 men and women from a random sample of the general population of the Ruhr industrial district in Germany. The study will focus on the direct detection of atherosclerosis instead of on risk factors that predict the probability of the disease.
EBT coronary calcium detection scanning will be compared with other measures of atherosclerosis in other vessels such as the carotid and peripheral arteries.
Imatrons primary product is the EBT scanner, which is now in use at more than 120 imaging facilities around the world.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.